106 related articles for article (PubMed ID: 14690525)
1. Differential enantioselective effects of pentyl-4-yn-valproate on spatial learning in the rat, and neurite outgrowth and cyclin D3 expression in vitro.
O'Loinsigh ED; Gherardini LM; Gallagher HC; Foley AG; Murphy KJ; Regan CM
J Neurochem; 2004 Jan; 88(2):370-9. PubMed ID: 14690525
[TBL] [Abstract][Full Text] [Related]
2. Multiple effects of pentyl-4-yn-VPA enantiomers: from toxicity to short-term memory enhancement.
Gotfryd K; Owczarek S; Hoffmann K; Klementiev B; Nau H; Berezin V; Bock E; Walmod PS
Neuropharmacology; 2007 Mar; 52(3):764-78. PubMed ID: 17095022
[TBL] [Abstract][Full Text] [Related]
3. Pentyl-4-yn-valproic acid enhances both spatial and avoidance learning, and attenuates age-related NCAM-mediated neuroplastic decline within the rat medial temporal lobe.
Murphy KJ; Fox GB; Foley AG; Gallagher HC; O'Connell A; Griffin AM; Nau H; Regan CM
J Neurochem; 2001 Aug; 78(4):704-14. PubMed ID: 11520891
[TBL] [Abstract][Full Text] [Related]
4. Pentyl-4-yn-VPA, a histone deacetylase inhibitor, ameliorates deficits in social behavior and cognition in a rodent model of autism spectrum disorders.
Foley AG; Cassidy AW; Regan CM
Eur J Pharmacol; 2014 Mar; 727():80-6. PubMed ID: 24486700
[TBL] [Abstract][Full Text] [Related]
5. Pentyl-4-yn-valproic acid reverses age-associated memory impairment in the Wistar rat.
Foley AG; Gallagher HC; Murphy KJ; Regan CM
Neurobiol Aging; 2004 Apr; 25(4):539-46. PubMed ID: 15013575
[TBL] [Abstract][Full Text] [Related]
6. Stereoselective dysmorphogenicity of the enantiomers of the valproic acid analogue 2-N-propyl-4-pentynoic acid (4-yn-VPA): cross-species evaluation in whole embryo culture.
Andrews JE; Ebron-McCoy MT; Bojic U; Nau H; Kavlock RJ
Teratology; 1997 May; 55(5):314-8. PubMed ID: 9261925
[TBL] [Abstract][Full Text] [Related]
7. Antiproliferative action of valproate is associated with aberrant expression and nuclear translocation of cyclin D3 during the C6 glioma G1 phase.
Bacon CL; Gallagher HC; Haughey JC; Regan CM
J Neurochem; 2002 Oct; 83(1):12-9. PubMed ID: 12358724
[TBL] [Abstract][Full Text] [Related]
8. Validation of an in vitro teratology system using chiral substances: stereoselective teratogenicity of 4-yn-valproic acid in cultured mouse embryos.
Andrews JE; Ebron-McCoy M; Bojic U; Nau H; Kavlock RJ
Toxicol Appl Pharmacol; 1995 Jun; 132(2):310-6. PubMed ID: 7785058
[TBL] [Abstract][Full Text] [Related]
9. Cell proliferation, migration and CAM-dependent neurite outgrowth as developmental in vitro endpoints for screening teratogenic potential: Application to valproic acid and related analogues of varying potency.
Bacon CL; Berezin V; Bode G; Bock E; Bojic U; Doherty P; Ehlers K; Ellerbeck U; Julien P; Kawa A; Maar TE; Nau H; Pirovano R; Regan CM; Schousboe A; Spezia F; Walsh FS; Williams EJ
Toxicol In Vitro; 1998 Apr; 12(2):101-9. PubMed ID: 20654391
[TBL] [Abstract][Full Text] [Related]
10. Valproic acid and its derivatives enhanced estrogenic activity but not androgenic activity in a structure dependent manner.
Stempin S; Andres S; Bumke Scheer M; Rode A; Nau H; Seidel A; Lampen A
Reprod Toxicol; 2013 Dec; 42():49-57. PubMed ID: 23892311
[TBL] [Abstract][Full Text] [Related]
11. S-2-pentyl-4-pentynoic hydroxamic acid and its metabolite s-2-pentyl-4-pentynoic acid in the NMRI-exencephaly-mouse model: pharmacokinetic profiles, teratogenic effects, and histone deacetylase inhibition abilities of further valproic acid hydroxamates and amides.
Eikel D; Hoffmann K; Zoll K; Lampen A; Nau H
Drug Metab Dispos; 2006 Apr; 34(4):612-20. PubMed ID: 16415118
[TBL] [Abstract][Full Text] [Related]
12. The enantiomers of the valproic acid analogue 2-n-propyl-4-pentynoic acid (4-yn-VPA): asymmetric synthesis and highly stereoselective teratogenicity in mice.
Hauck RS; Nau H
Pharm Res; 1992 Jul; 9(7):850-5. PubMed ID: 1437995
[TBL] [Abstract][Full Text] [Related]
13. Prediction of embryotoxic effects of valproic acid-derivatives with molecular in vitro methods.
Lampen A; Göttlicher M; Nau H
ALTEX; 2001; 18(2):123-6. PubMed ID: 11378687
[TBL] [Abstract][Full Text] [Related]
14. Enantioselective apoptosis induction in histiocytic lymphoma cells and acute promyelocytic leukemia cells.
Ivanova D; Gronemeyer H; Steinberg P; Nau H
Arch Toxicol; 2013 Feb; 87(2):303-10. PubMed ID: 23010695
[TBL] [Abstract][Full Text] [Related]
15. Valproate reversibly reduces neurite outgrowth by human SY5Y neuroblastoma cells.
Qian Y; Zheng Y; Tiffany-Castiglioni E
Brain Res; 2009 Dec; 1302():21-33. PubMed ID: 19766605
[TBL] [Abstract][Full Text] [Related]
16. Modulation of synaptic transmission and analysis of neuroprotective effects of valproic Acid and derivates in rat embryonic motoneurons.
Ragancokova D; Song Y; Nau H; Dengler R; Krampfl K; Petri S
Cell Mol Neurobiol; 2010 Aug; 30(6):891-900. PubMed ID: 20422280
[TBL] [Abstract][Full Text] [Related]
17. Prediction of teratogenic potency of valproate analogues using cerebellar aggregation cultures.
Maar TE; Ellerbeck U; Bock E; Nau H; Schousboe A; Berezin V
Toxicology; 1997 Jan; 116(1-3):159-68. PubMed ID: 9020517
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the anticonvulsant profile and enantioselective pharmacokinetics of the chiral valproylamide propylisopropyl acetamide in rodents.
Isoherranen N; Yagen B; Woodhead JH; Spiegelstein O; Blotnik S; Wilcox KS; Finnell RH; Bennett GD; White HS; Bialer M
Br J Pharmacol; 2003 Feb; 138(4):602-13. PubMed ID: 12598414
[TBL] [Abstract][Full Text] [Related]
19. Gadd45a, the gene induced by the mood stabilizer valproic acid, regulates neurite outgrowth through JNK and the substrate paxillin in N1E-115 neuroblastoma cells.
Yamauchi J; Miyamoto Y; Murabe M; Fujiwara Y; Sanbe A; Fujita Y; Murase S; Tanoue A
Exp Cell Res; 2007 May; 313(9):1886-96. PubMed ID: 17428471
[TBL] [Abstract][Full Text] [Related]
20. The enantioselective teratogenicity of 2-n-propyl-4-pentynoic acid (4-yn-VPA) is due to stereoselective intrinsic activity and not differences in pharmacokinetics.
Hauck RS; Elmazar MM; Plum C; Nau H
Toxicol Lett; 1992 Apr; 60(2):145-53. PubMed ID: 1570629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
